Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ELDN stock hub

Eledon Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ELDNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

294.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ELDN

In the news

Latest news · ELDN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-35.8

P25 -106.6P50 -46.9P75 -3.1

ROIC-6,771.1

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ELDN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001404281
Company name	Eledon Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	28617K101
Employees	33
Employees Change	2%
Employees Change Percent	6.45
Enterprise value	$162.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US28617K1016
Last refreshed	2026-05-10
Market cap	$294.7M
Market cap category	Micro-Cap
Price	$3.88
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	ELDN
Website	https://eledon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.48%
FCF yield	-21.15%
P/B ratio	2.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-45.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.4M
ROA	-30.04
Roa5y	-24.82
ROCE	-55.26
ROE	-35.79
Roe5y	-87.78
ROIC	-6,771.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	29.36%
Cagr3y	13.12%
Cagr5y	-15.21%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$169M
Cash	$133.3M
Current Assets	$135.7M
Current Liabilities	$18.3M
Debt	$641,000
Debt Equity	$0
Equity	$136.8M
Liabilities	$32.2M
Long Term Assets	$33.3M
Long Term Liabilities	$13.9M
Net Cash	$132.7M
Net Cash By Market Cap	$45.02
Net Cash Growth	-4.69%
Net Debt Equity	$-0.97
Tangible Book Value	$104.4M
Tangible Book Value Per Share	$1.38
WACC	9.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.4
Net Working Capital	$-15.6M
Quick ratio	7.3
Working Capital	$117.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-68.42%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	29.33%
200-day SMA	2.61
3Y total return	44.78%
50-day SMA	3.19
50-day SMA vs 200-day SMA	50over200
5Y total return	-56.16%
All Time High	155
All Time High Change	-97.5%
All Time High Date	2018-06-01
All Time Low	1.07
All Time Low Change	262.62%
All Time Low Date	2023-11-09
ATR	0.24
Beta	0.95
Beta1y	1.9
Beta2y	1.42
Ch YTD	157
High	4
High52	4.6
High52 Date	2025-11-03
High52ch	-15.65%
Low	3.84
Low52	1.35
Low52 Date	2025-11-21
Low52ch	187.41%
Ma50ch	21.78%
Premarket Change Percent	2.07
Premarket Price	$3.94
Premarket Volume	1,145
Price vs 200-day SMA	48.72%
RSI	64.11
RSI Monthly	54.04
RSI Weekly	65.62
Sharpe ratio	0.76x
Sortino ratio	1.06
Total Return	-68.42%
Tr YTD	157
Tr1m	27.21%
Tr1w	5.15%
Tr3m	77.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$8
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.23
Operating Income	$-83.3M
Price target	$8.5
Price Target Change	$119
Price Target Change Top	$106

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	68,697,735%
Float Percent	90.43%
Shares Insiders	0.06%
Shares Institutions	54.77%
Shares Out	75,966,230
Shares Qo Q	24.26%
Shares Yo Y	68.42%
Short Float	11.37%
Short Ratio	5.14
Short Shares	10.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-72.8M
Average Volume	1,753,986.15x
Bv Per Share	1.81
Ch1m	27.21
Ch1w	5.15
Ch1y	29.33
Ch3m	77.17
Ch3y	44.78
Ch5y	-56.16
Ch6m	88.35
Change	0.52%
Change From Open	0.26
Close	3.86
Days Gap	0.26
Dollar Volume	4,314,532.8
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-83.3M
EPS	$-0.56
F Score	0
FCF	$-62.3M
FCF EV Yield	-38.47x
FCF Per Share	$-0.82
Financing CF	53,807,000
Fiscal Year End	December
Founded	2,004
Income Tax	$35,000
Investing CF	10,793,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Date	2020-10-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-19
Ma150	2.57
Ma150ch	51.09%
Ma20	3.66
Ma20ch	5.9%
Net CF	2,259,000
Next Earnings Date	2026-05-22
Open	3.87
Optionable	Yes
Position In Range	25.81
Post Close	3.88
Postmarket Change Percent	0.2
Postmarket Price	$3.89
Ppne	613,000
Pre Close	3.86
Price Date	2026-05-08
Ptbv Ratio	2.82
Relative Volume	0.63x
Share Based Comp	10,451,000
Tr6m	88.35%
Us State	California
Volume	1,111,993

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ELDN pay a dividend?

Capital-return profile for this ticker.

Performance

ELDN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ELDN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+54.8%

Float: +90.4% of shares outstanding

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ELDN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.1

Neutral momentum band

Price vs 200-day MA

+48.7%

50/200-day relationship not available

Beta (5Y)

0.95

Moves roughly with the market

Sharpe ratio

0.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ELDN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ELDN stock rating?

Eledon Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ELDN analysis?

The full report lives at /stocks/ELDN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ELDN?

The latest report frames ELDN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ELDN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.